Cessatech AS (XSAT:CESSA) Days Payable : 0.00 (As of Mar. 2025)

View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Days Payable?

Cessatech AS's average Accounts Payable for the three months ended in Mar. 2025 was kr1.99 Mil. Cessatech AS's Cost of Goods Sold for the three months ended in Mar. 2025 was kr0.00 Mil.

The historical rank and industry rank for Cessatech AS's Days Payable or its related term are showing as below:

XSAT:CESSA's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 119.305
* Ranked among companies with meaningful Days Payable only.

Cessatech AS's Days Payable stayed the same from Mar. 2024 (0.00) to Mar. 2025 (0.00). stayed the same

Cessatech AS Days Payable Historical Data

The historical data trend for Cessatech AS's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Days Payable Chart

Cessatech AS Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Days Payable

Cessatech AS Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Days Payable	Get a 7-Day Free Trial														-	-	-	-	-

Competitive Comparison of Cessatech AS's Days Payable

For the Biotechnology subindustry, Cessatech AS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cessatech AS's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cessatech AS's Days Payable distribution charts can be found below:

* The bar in red indicates where Cessatech AS's Days Payable falls into.

Save Embed

;

Save Embed

;

Cessatech AS Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Cessatech AS's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as

	Days Payable (A: Dec. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2023 )	+	Accounts Payable (A: Dec. 2024 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2024 )	*	Days in Period
=	( (0.657	+	1.242)	/	2 )	/	0	*	365
=	0.9495					/	0	*	365
=	N/A

Cessatech AS's Days Payable for the quarter that ended in Mar. 2025 is calculated as:

	Days Payable (Q: Mar. 2025 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2024 )	+	Accounts Payable (Q: Mar. 2025 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2025 )	*	Days in Period
=	( (1.242	+	2.744)	/	2 )	/	0	*	365 / 4
=	1.993					/	0	*	365 / 4
=	N/A

Cessatech AS Days Payable Related Terms

Thank you for viewing the detailed overview of Cessatech AS's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Cessatech AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

8GN:Germany

Address

Strandvejen 60, Hellerup, DNK, DK- 2900

Website

https://www.cessatech.com

Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based medicines for children for the treatment of paediatric acute pain. Its product (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children. Its other products CT002 which is a Non-invasive nasal spray and CT003 which is a local anaesthetic gel are in different stages development.

Cessatech AS Headlines

No Headlines